菊粉在牙周治疗前后辅助牙周健康:随机对照试验研究方案
本研究为单中心、随机、双盲、安慰剂对照试验,计划招募170名接受牙周洁治术(ST)的牙周病患者,随机分为菊粉组或安慰剂(麦芽糊精)组,干预从ST前4周持续至ST后10周随访。主要目的是确定菊粉是否比安慰剂更有效地改善临床牙周结局(探诊深度PD和探诊出血BOP),次要目的包括评估菊粉对唾液炎症标志物和牙周病原体的影响。
要点
- 菊粉干预从ST前4周开始至ST后10周,评估对PD和BOP的影响。
- 次要结局包括唾液炎症标志物和牙周病原体的变化。
- 嵌入48名参与者的预试验以测试可行性。
核心结论
- 预期菊粉将增强ST对牙周病管理的积极效果,为益生元作为ST辅助手段提供依据。
研究设计与样本
- 单中心、随机、双盲、安慰剂对照试验,计划招募170名接受ST的牙周病患者,随机分为菊粉组或安慰剂(麦芽糊精)组。
- 嵌入预试验使用前48名参与者测试可行性。
- 干预从ST前4周开始至ST后10周随访。
主要发现
- 主要结局为临床牙周指标包括PD≥4mm位点数和BOP存在,在基线和ST后测量。
- 次要结局包括唾液炎症标志物、牙周病原体、体重指数和饮食,在基线、ST前(干预4周后)和ST后(干预14周后)测量。
临床怎么用
- 若结果阳性,可考虑在ST前和ST期间补充菊粉以辅助牙周健康管理。
局限性
- 研究方案阶段,尚未报告实际结果。
- 单中心设计可能限制普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periodontal disease is a chronic state of inflammation that can destroy the supporting tissues around the teeth, leading to the resorption of alveolar bone. The initial strategy for treating periodontal disease is non-surgical sanative therapy (ST). Periodontal disease can also induce dysbiosis in the gut microbiota and contribute to low-grade systemic inflammation. Prebiotic fibers such as inulin can selectively alter the intestinal microbiota and support homeostasis by improving gut barrier functions and preventing inflammation. Providing an inulin supplement prior to and post-ST may influence periodontal health while providing insight into the complex relationship between periodontal disease and the gut microbiota. The primary objective is to determine if inulin is more effective than the placebo at improving clinical periodontal outcomes including probing depth (PD) and bleeding on probing (BOP). Secondary objectives include determining the effects of inulin supplementation pre- and post-ST on salivary markers of inflammation and periodontal-associated pathogens, as these outcomes reflect more rapid changes that can occur. METHODS: We will employ a single-center, randomized, double-blind, placebo-controlled study design and recruit and randomize 170 participants who are receiving ST to manage the periodontal disease to the intervention (inulin) or placebo (maltodextrin) group. A pilot study will be embedded within the randomized controlled trial using the first 48 participants to test the feasibility for the larger, powered trial. The intervention period will begin 4 weeks before ST through to their follow-up appointment at 10 weeks post-ST. Clinical outcomes of periodontal disease including the number of sites with PD ≥ 4 mm and the presence of BOP will be measured at baseline and post-ST. Salivary markers of inflammation, periodontal-associated pathogens, body mass index, and diet will be measured at baseline, pre-ST (after 4 weeks of intervention), and post-ST (after 14 weeks of intervention). DISCUSSION: We expect that inulin will enhance the positive effect of ST on the management of periodontal disease. The results of the study will provide guidance regarding the use of prebiotics prior to and as a supportive adjunct to ST for periodontal health. TRIAL REGISTRATION: ClinicalTrials.gov NCT04670133 . Registered on 17 December 2020.
引用
- Zanatta CAR, Fritz PC, Comelli EM, et al. Intervention with inulin prior to and during sanative therapy to further support periodontal health: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34376241. doi:10.1186/s13063-021-05504-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。